Pàgina inicial > Resultats de la cerca: Brendel, Matthias
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 4 registres trobats en 0.03 segons.
Articles, 4 registres trobats
Articles 4 registres trobats  
1.
11 p, 2.6 MB Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies / Huber, Maria (LMU Munich) ; Beyer, Leonie (LMU Munich) ; Prix, Catharina (LMU Munich) ; Schönecker, Sonja (LMU Munich) ; Palleis, Carla (LMU Munich) ; Rauchmann, Boris-Stephan (LMU Munich) ; Morbelli, Silvia (University of Genoa) ; Chincarini, Andrea (Genoa section) ; Bruffaerts, Rose (University Hospitals Leuven (Bèlgica)) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Van Laere, Koen (University Hospitals Leuven (Bèlgica)) ; Kramberger, Milica G. (University Medical Centre) ; Trost, Maja (University Medical Centre) ; Grmek, Marko (University Medical Centre) ; Garibotto, Valentina (Geneva University) ; Nicastro, Nicolas (University of Cambridge) ; Frisoni, Giovanni B. (Geneva University Hospitals) ; Lemstra, Afina W. (VU Medical Center Alzheimer Center) ; van der Zande, Jessica (VU Medical Center Alzheimer Center) ; Pilotto, Andrea (Isidoro Hospital) ; Padovani, Alessandro (University of Brescia) ; Garcia-Ptacek, Sara (Internal Medicine) ; Savitcheva, Irina (Karolinska University Hospital and Karolinska Institutet (Suecia)) ; Ochoa-Figueroa, Miguel A. (Linköping University) ; Davidsson, Anette (Linköping University Hospital) ; Camacho, Valle (Institut d'Investigació Biomèdica Sant Pau) ; Peira, Enrico (University of Genoa) ; Arnaldi, Dario (University of Genoa) ; Bauckneht, Matteo (University of Genoa) ; Pardini, Matteo (Clinical Neurology. Department of Neuroscience (DINOGMI). University of Genoa) ; Sambuceti, Gianmario (University of Genoa) ; Vöglein, Jonathan (DZNE-German Center for Neurodegenerative Diseases) ; Schnabel, Jonas (LMU Munich) ; Unterrainer, Marcus (LMU Munich) ; Perneczky, Robert (University of Munich) ; Pogarell, Oliver (LMU Munich) ; Buerger, Katharina (University of Munich) ; Catak, Cihan (University of Munich) ; Bartenstein, Peter (Munich Cluster for Systems Neurology (SyNergy)) ; Cumming, Paul (Queensland University of Technology) ; Ewers, Michael (DZNE-German Center for Neurodegenerative Diseases) ; Danek, Adrian (Ludwig-Maximilians-Universität) ; Levin, Johannes (Munich Cluster for Systems Neurology (SyNergy)) ; Aarsland, Dag (King's College London) ; Nobili, Flavio (University of Genoa) ; Rominger, Axel (University of Bern) ; Brendel, Matthias (Munich Cluster for Systems Neurology (SyNergy)) ; Universitat Autònoma de Barcelona
Striatal dopamine deficiency and metabolic changes are well-known phenomena in dementia with Lewy bodies and can be quantified in vivo by I-Ioflupane brain single-photon emission computed tomography of dopamine transporter and F-fluorodesoxyglucose PET. [...]
2020 - 10.1002/mds.27945
Movement Disorders, Vol. 35 Núm. 4 (january 2020) , p. 595-605  
Registre complet - Creative Commons
2.
15 p, 2.9 MB Adopting transfer learning for neuroimaging : a comparative analysis with a custom 3D convolution neural network model / Soliman, Amira (Halmstad University) ; Chang, Jose R. (National Cheng Kung University in Tainan) ; Etminani, Kobra (Halmstad University) ; Byttner, Stefan (Halmstad University) ; Davidsson, Anette (Institution of Medicine and Health Sciences) ; Martínez-Sanchis, Begoña (Hospital Universitari i Politècnic La Fe (València)) ; Camacho, Valle (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Bauckneht, Matteo (IRCCS Ospedale Policlinico San Martino) ; Stegeran, Roxana (Linköping University Hospital) ; Ressner, Marcus (Linköping University Hospital) ; Agudelo-Cifuentes, Marc (Hospital Universitari i Politècnic La Fe (València)) ; Chincarini, Andrea (National Institute of Nuclear Physics) ; Brendel, Matthias (University Hospital) ; Rominger, Axel (University Hospital Bern) ; Bruffaerts, Rose (University of Antwerp) ; Vandenberghe, Rik (University Hospitals Leuven (Bèlgica)) ; Kramberger, Milica G. (University Medical Centre) ; Trost, Maja (Univerza V Ljubljani) ; Nicastro, Nicolas (Geneva University Hospitals (Suïssa)) ; Frisoni, Giovanni B. (University Hospitals) ; Lemstra, Afina W. (VU Medical Center Alzheimer Center) ; Berckel, Bart N. M. van (Vrije Universiteit Amsterdam) ; Pilotto, Andrea (University of Brescia) ; Padovani, Alessandro (IRCCS Ospedale Policlinico San Martino) ; Morbelli, Silvia (Stavanger University Hospital) ; Aarsland, Dag (King's College London) ; Nobili, Flavio (University of Genoa) ; Garibotto, Valentina (Geneva University) ; Ochoa-Figueroa, Miguel (Linköping University) ; Universitat Autònoma de Barcelona
In recent years, neuroimaging with deep learning (DL) algorithms have made remarkable advances in the diagnosis of neurodegenerative disorders. However, applying DL in different medical domains is usually challenged by lack of labeled data. [...]
2022 - 10.1186/s12911-022-02054-7
BMC Medical Informatics and Decision Making, Vol. 22 (december 2022)  
Registre complet - Creative Commons
3.
22 p, 3.7 MB A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET / Etminani, Kobra (Center for Applied Intelligent Systems Research (CAISR). Halmstad University) ; Soliman, Amira (Center for Applied Intelligent Systems Research (CAISR). Halmstad University) ; Davidsson, Anette (Department of Clinical Physiology. Department of Health. Medicine and Caring Sciences. Linköping University) ; Chang, Jose R. (National Cheng Kung University in Tainan) ; Martínez-Sanchis, Begoña (Hospital Universitari i Politècnic La Fe (València)) ; Byttner, Stefan (Center for Applied Intelligent Systems Research (CAISR). Halmstad University) ; Camacho, Valle (Institut d'Investigació Biomèdica Sant Pau) ; Bauckneht, Matteo (Nuclear Medicine Unit. IRCCS Ospedale Policlinico San Martino) ; Stegeran, Roxana (Department of Diagnostic Radiology. Linköping University Hospital) ; Ressner, Marcus (Department of Medical Physics. Linköping University Hospital) ; Agudelo-Cifuentes, Marc (Hospital Universitari i Politècnic La Fe (València)) ; Chincarini, Andrea (National Institute of Nuclear Physics (INFN)) ; Brendel, Matthias (Department of Nuclear Medicine. University Hospital. LMU Munich) ; Rominger, Axel (Department of Nuclear Medicine. Inselspital. University Hospital Bern) ; Bruffaerts, Rose (Biomedical Research Institute. Hasselt University) ; Vandenberghe, Rik (Neurology Department. University Hospitals Leuven) ; Kramberger, Milica G. (Department of Neurology. University Medical Centre) ; Trost, Maja (Univerza V Ljubljani) ; Nicastro, Nicolas (Department of Clinical Neurosciences. Geneva University Hospitals) ; Frisoni, Giovanni B. (LANVIE (Laboratoire de Neuroimagerie du Vieillissement). Department of Psychiatry. University Hospitals) ; Lemstra, Afina W. (Department of Neurology. Alzheimer Center) ; van Berckel, Bart N.M. (Department of Radiology & Nuclear Medicine. Amsterdam UMC. location VUmc) ; Pilotto, Andrea (Parkinson's Disease Rehabilitation Centre) ; Padovani, Alessandro (Neurology Unit. Department of Clinical and Experimental Sciences. University of Brescia) ; Morbelli, Silvia (Department of Health Sciences. University of Genoa) ; Aarsland, Dag (Department of Old Age Psychiatry. Institute of Psychiatry. Psychology and Neuroscience. King's College London) ; Nobili, Flavio (Clinical Neurology. IRCCS Ospedale Policlinico San Martino) ; Garibotto, Valentina (Division of Nuclear Medicine and Molecular Imaging. University Hospitals of Geneva and NIMTLab. Faculty of Medicine. University of Geneva) ; Ochoa-Figueroa, Miguel (Center for Medical Image Science and Visualization (CMIV). Linköping University) ; Universitat Autònoma de Barcelona
Purpose: The purpose of this study is to develop and validate a 3D deep learning model that predicts the final clinical diagnosis of Alzheimer's disease (AD), dementia with Lewy bodies (DLB), mild cognitive impairment due to Alzheimer's disease (MCI-AD), and cognitively normal (CN) using fluorine 18 fluorodeoxyglucose PET (18F-FDG PET) and compare model's performance to that of multiple expert nuclear medicine physicians' readers. [...]
2022 - 10.1007/s00259-021-05483-0
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49 Núm. 2 (january 2022) , p. 563-584  
Registre complet - Creative Commons
4.
11 p, 519.1 KB 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers / Suárez-Calvet, Marc (German Center for Neurodegenerative Diseases (DZNE) Munich) ; Kleinberger, Gernot (Munich Cluster for Systems Neurology (SyNergy)) ; Araque Caballero, Miguel Ángel (Ludwig-Maximilians-University Munich) ; Brendel, Matthias (Ludwig-Maximilians-University Munich) ; Rominger, Axel (Ludwig-Maximilians-University Munich) ; Alcolea, Daniel (Institut d'Investigació Biomèdica Sant Pau) ; Fortea, Juan (Institut d'Investigació Biomèdica Sant Pau) ; Lleó, Alberto (Institut d'Investigació Biomèdica Sant Pau) ; Blesa, Rafael (Institut d'Investigació Biomèdica Sant Pau) ; Gispert, Juan Domingo (Institut d'Investigació Biomèdica Sant Pau) ; Sanchez-Valle, Raquel (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Antonell, Anna (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Rami Gonzalez, Lorena (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Molinuevo, José Luis (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Brosseron, Frederic (German Center for Neurodegenerative Diseases (DZNE)) ; Traschütz, Andreas (Universitätsklinikum Bonn) ; Heneka, Michael T. (Universitätsklinikum Bonn) ; Struyfs, Hanne (University Hospital Antwerp (Bèlgica)) ; Engelborghs, Sebastiaan (University Hospital Antwerp (Bèlgica)) ; Sleegers, Kristel (University of Antwerp. Institute Born-Bunge) ; Van Broeckhoven, Christine (University of Antwerp. Institute Born-Bunge) ; Zetterberg, Henrik (UCL Institute of Neurology (Regne Unit)) ; Nellgård, Bengt (Gothenburg University. Sahlgrenska Academy. Institute of Clinical Sciences) ; Blennow, Kaj (The Sahlgrenska Academy at the University of Gothenburg. Institute of Neuroscience and Physiology) ; Crispin, Alexander (Institute of Medical Informatics, Biometry, and Epidemiology) ; Ewers, Michael (Ludwig-Maximilians-University Munich) ; Haass, Christian (BioMedical Center (BMC), Biochemistry, Ludwig-Maximilians-University Munich) ; Universitat Autònoma de Barcelona
2 is an innate immune receptor expressed on the surface of microglia. Loss-of-function mutations of 2 are associated with increased risk of Alzheimer's disease (). 2 is a type-1 protein with an ectodomain that is proteolytically cleaved and released into the extracellular space as a soluble variant (2), which can be measured in the cerebrospinal fluid (). [...]
2016 - 10.15252/emmm.201506123
EMBO Molecular Medicine, Vol. 8 (march 2016) , p. 466-476  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
1 Brendel, M. R.
1 Brendel, M.R.
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem